Taro Pharmaceutical Industries Ltd. Ordinary Shares (NYSE: TARO)
50 Days left to seek lead plaintiff status.
On September 9, 2024, Taro Pharmaceutical Industries Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of former shareholders of Taro Pharmaceutical Industries Ltd. in connection with the acquisition (the “Transaction”) of Taro by Sun Pharmaceutical Industries Ltd.